Vanguard holds 6.87% of Hinge Health (HNGE) stock for its clients

Rhea-AI Filing Summary

The Vanguard Group reports beneficial ownership of 2,605,532 shares of Hinge Health Inc common stock, representing 6.87% of the class as of 12/31/2025.

Vanguard reports no sole voting or dispositive power, with shared voting power over 121,736 shares and shared dispositive power over 2,605,532 shares. The securities are held for Vanguard’s clients, who are entitled to dividends and sale proceeds, and no single other person has an interest over 5% of the class.

Vanguard certifies the holdings are in the ordinary course of business and not for the purpose of changing or influencing control of Hinge Health. Vanguard also notes an internal realignment on January 12, 2026, after which certain subsidiaries or business divisions may report beneficial ownership separately.

Insights

Institutional ownership and governance analyst

Vanguard discloses a passive 6.87% stake in Hinge Health held for its clients.

The Vanguard Group reports beneficial ownership of 2,605,532 Hinge Health common shares, equal to 6.87% of the class. It reports no sole voting or dispositive power, with shared voting power over 121,736 shares and shared dispositive power over all 2,605,532 shares.

The filing states the position is held in the ordinary course of business and not to change or influence control, which is characteristic of a passive Schedule 13G institutional holder. Economic rights to dividends and sale proceeds belong to Vanguard’s clients, and no single other person has more than 5% of the class through these holdings.

Vanguard also describes an internal realignment effective January 12, 2026, after which certain subsidiaries or business divisions may report beneficial ownership separately on a disaggregated basis. Subsequent ownership reports for Hinge Health may therefore show changes in reporting entities even if underlying client strategies remain the same.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Hinge Health Inc

(Name of Issuer)

Common Stock

(Title of Class of Securities)

433313103

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 433313103

1

Names of Reporting Persons

The Vanguard Group

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

PENNSYLVANIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 121,736.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,605,532.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,605,532.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.87 %

12

Type of Reporting Person (See Instructions)

IA

Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. As of that date, The Vanguard Group, Inc. no longer performs portfolio management services or administers proxy voting. In accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. anticipates that certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that currently have, or are deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Hinge Health Inc
(b)	Address of issuer's principal executive offices: 455 Market Street, Suite 700, San Francisco, CA, 94105
Item 2.
(a)	Name of person filing: The Vanguard Group
(b)	Address or principal business office or, if none, residence: 100 Vanguard Blvd., Malvern, PA 19355
(c)	Citizenship: PA
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 433313103
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 2605532
(b)	Percent of class: 6.87 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 121736
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 2605532
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein. No one other person's interest in the securities reported herein is more than 5%.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

The Vanguard Group

Signature:	Ashley Grim
Name/Title:	Head of Global Fund Administration
Date:	01/30/2026

FAQ

How much of Hinge Health Inc (HNGE) does The Vanguard Group own?

The Vanguard Group reports beneficial ownership of 2,605,532 Hinge Health common shares, representing 6.87% of the class. This stake is reported on a Schedule 13G as of December 31, 2025, indicating a significant but passive institutional holding in the company.

Does Vanguard control voting for its Hinge Health (HNGE) shares?

Vanguard reports no sole voting power and shared voting power over 121,736 Hinge Health shares. It has shared dispositive power over 2,605,532 shares, meaning decisions about selling those shares are shared, and the position is certified as not aimed at influencing control.

Who benefits economically from Vanguard’s Hinge Health (HNGE) holdings?

Vanguard states its clients have rights to dividends and sale proceeds from the reported Hinge Health shares. These clients include registered investment companies and other managed accounts, and no single other person’s interest in the reported securities exceeds five percent of the class.

Is Vanguard’s 6.87% Hinge Health (HNGE) stake considered passive?

Yes. Vanguard certifies the Hinge Health shares are held in the ordinary course of business and not to influence control. The Schedule 13G specifically states the securities were not acquired for changing or influencing control of the issuer.

What internal changes at Vanguard affect this Hinge Health (HNGE) filing?

Vanguard notes an internal realignment effective January 12, 2026. After this date, certain subsidiaries or business divisions that have or are deemed to have beneficial ownership may report on a disaggregated basis, although they pursue the same investment strategies as before.

What type of filing did Vanguard submit for its Hinge Health (HNGE) position?

Vanguard submitted a Schedule 13G for its Hinge Health common stock holdings. This form is used by qualified investors to report beneficial ownership of more than five percent of a class of equity securities when holdings are maintained on a passive basis.